|
|
| (2 intermediate revisions by the same user not shown) |
| Line 3: |
Line 3: |
| | issue date = 04/17/2017 | | | issue date = 04/17/2017 |
| | title = Shine Medical Technologies, Inc. - Acknowledgment of Change of Mailing Address | | | title = Shine Medical Technologies, Inc. - Acknowledgment of Change of Mailing Address |
| | author name = Lynch S T | | | author name = Lynch S |
| | author affiliation = NRC/NRR/DPR/PRLB | | | author affiliation = NRC/NRR/DPR/PRLB |
| | addressee name = Piefer G | | | addressee name = Piefer G |
| Line 9: |
Line 9: |
| | docket = 05000608 | | | docket = 05000608 |
| | license number = CPMIF-001 | | | license number = CPMIF-001 |
| | contact person = Lynch S T | | | contact person = Lynch S |
| | document type = Letter | | | document type = Letter |
| | page count = 1 | | | page count = 1 |
| Line 15: |
Line 15: |
|
| |
|
| =Text= | | =Text= |
| {{#Wiki_filter:April 17, 2017 | | {{#Wiki_filter:April 17, 2017 Gregory Piefer, Ph.D. |
| | | Chief Executive Officer SHINE Medical Technologies, Inc. |
| Gregory Piefer, Ph.D. | | 101 E. Milwaukee Street, Suite 600 Janesville, WI 53545 |
| | |
| Chief Executive Officer SHINE Medical Technologies, Inc. 101 E. Milwaukee Street, Suite 600 Janesville, WI 53545 | |
|
| |
|
| ==SUBJECT:== | | ==SUBJECT:== |
| SHINE MEDICAL TECHNOLOGIES, INC. - ACKNOWLEDGMENT OF CHANGE OF MAILING ADDRESS | | SHINE MEDICAL TECHNOLOGIES, INC. - ACKNOWLEDGMENT OF CHANGE OF MAILING ADDRESS |
|
| |
|
| ==Dear Dr. Piefer:== | | ==Dear Dr. Piefer:== |
|
| |
|
| By letter dated December 9, 2016 (Agencywide Documents Access and Management System [ADAMS] Accession No. ML16344A021), SHINE Medical Technologies, Inc. (SHINE) informed the U.S. Nuclear Regulatory Commission ( | | By letter dated December 9, 2016 (Agencywide Documents Access and Management System |
| NRC) of a change in its mailing address. | | [ADAMS] Accession No. ML16344A021), SHINE Medical Technologies, Inc. (SHINE) informed the U.S. Nuclear Regulatory Commission (NRC) of a change in its mailing address. |
| | | The NRC has updated its records to reflect this change and will send all correspondence to the following mailing address: |
| The NRC has updated its records to reflect this change and will send all correspondence to the | | SHINE Medical Technologies, Inc. |
| | | 101 E. Milwaukee Street, Suite 600 Janesville, WI 53545 If you have any questions, please contact Steven Lynch at 301-415-1524, or by electronic mail at Steven.Lynch@nrc.gov. |
| following mailing address: | | Sincerely, |
| | | /RA/ |
| SHINE Medical Technologies, Inc. 101 E. Milwaukee Street, Suite 600 Janesville, WI 53545 | | Steven T. Lynch, Project Manager Research and Test Reactors Licensing Branch Division of Policy and Rulemaking Office of Nuclear Reactor Regulation Docket No. 50-608 |
| | |
| If you have any questions, please contact Steven Lynch at 301-415-1524, or by electronic mail at Steven.Lynch@nrc.gov | |
| . Sincerely,
| |
| | |
| /RA/ Steven T. Lynch, Project Manager Research and Test Reactors Licensing Branch
| |
| | |
| Division of Policy and Rulemaking Office of Nuclear Reactor Regulation Docket No. 50-608 | |
|
| |
|
| ML17102B375; *concurred via email NRR-088 OFFICE NRR/DPR/PRLB/PM* NRR/DPR/PROB/LA* NRR/DPR/PRLB/BC NAME SLynch NParker AAdams DATE 4/13/17 4/13/17 4/17/17}} | | ML17102B375; *concurred via email NRR-088 OFFICE NRR/DPR/PRLB/PM* NRR/DPR/PROB/LA* NRR/DPR/PRLB/BC NAME SLynch NParker AAdams DATE 4/13/17 4/13/17 4/17/17}} |
|
|---|
Category:Letter
MONTHYEARML24128A2162024-05-0707 May 2024
Shine Technologies, LLC, Submittal of Annual Financial Report
ML24047A0392024-02-16016 February 2024
Shine Technologies, LLC - Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001
ML23229A0202023-08-17017 August 2023
Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001
ML23087A2272023-05-0505 May 2023
Shine Technologies, LLC - Issuance of Amendment No. 4 to Construction Permit No. CPMIF-001 for the Receipt and Possession of Contained Special Nuclear Material
ML23086C0502023-04-27027 April 2023
Shine Technologies, LLC - Letter, Environmental Assessment and Finding of No Significant Impact
ML23088A3382023-04-0505 April 2023
Shine Technologies, LLC - Review of the Physical Security Plan in Support of an Operating License for a Medical Radioisotope Production Facility
ML23010A1982023-02-24024 February 2023
Shine Technologies, LLC - Letter: Safety Evaluation Report for the Shine Medical Radioisotope Production Facility Operating License Application
ML23048A2442023-02-17017 February 2023
Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 Response to Request for Additional Information
ML23010A2382023-02-0303 February 2023
Shine Technologies, LLC - Individual Notice of Consideration FRN Letter
ML23034A1872023-02-0303 February 2023
Shine Medical Technologies, LLC Notice of Availability of Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility (Docket Number: 50-608)
ML23023A0922023-02-0202 February 2023
Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility
ML23023A0942023-02-0202 February 2023
Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility
ML23023A0862023-02-0202 February 2023
Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility
ML23024A1682023-02-0101 February 2023
Letter to Ken Westlake, EPA Region 5 - Issuance of Final EIS Supplement Related to the Operating License
ML22287A1852023-02-0101 February 2023
Shine Technologies, LLC Regulatory Report on the Audit of Phased Startup Operations Application Supplement
ML23024A1742023-02-0101 February 2023
Dr. Gregory Piefer, Chief Executive Officer - Issuance of Final EIS Supplement Related to the Operating License
ML22308A2332023-01-0909 January 2023
Shine Technologies LLC - Regulatory Audit Report for Chapter 8 - Irradiation Facility and Radioisotope Production Facility Electrical Power Systems
ML22347A2142023-01-0404 January 2023
Shine Technologies LLC - Regulatory Audit Report for I&C Combined Sessions
ML22356A1932022-12-22022 December 2022
Shine Technologies, LLC Application for an Operating License - Response to Request for Confirmatory Information
ML22347A1772022-12-14014 December 2022
Shine Technologies LLC - Regulatory Audit Report for Programmable Logic Lifecycle
ML22301A1492022-12-0707 December 2022
Shine Technologies, LLC - Regulatory Audit Report for Chapter 13 - Accident Analysis and Criticality Safety
ML22322A2122022-12-0202 December 2022
Shine Medical Technologies - Cybersecurity Audit Summary Report
ML22322A2232022-12-0202 December 2022
Shine Medical Technologies - Fire Protection Audit Summary Report
ML22348A0672022-12-0101 December 2022
Shine Technologies, LLC - Request for Confirmatory Information Related to Instrumentation and Control Systems
ML22335A5722022-12-0101 December 2022
Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information
ML22292A3192022-11-30030 November 2022
Shine Medical Technologies, LLC Issuance of Order and Amendment No. 3 to Construction Permit No. CPMIF-001
ML22318A1782022-11-14014 November 2022
Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information
ML22304A1262022-10-31031 October 2022
Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information
ML22279A9512022-10-0606 October 2022
Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001
ML22271A9632022-09-28028 September 2022
Shine Technologies, LLC Application for an Operating License Supplement No. 31 Revision to the Phased Startup Operations Application Supplement
ML22263A3442022-09-20020 September 2022
Shine Technologies, LLC Application for an Operating License - Response to Request for Additional Information
ML22263A0272022-09-19019 September 2022
Shine Technologies, LLC - Application for an Operating License - Response to Request for Confirmatory Information
ML22220A2612022-09-12012 September 2022
Shine Technologies LLC - Regulatory Report on the Audit Chapter 14, Technical Specifications
ML22251A3272022-09-0808 September 2022
Shine Technologies, LLC Application for an Operating License Revision 1 of Shine Response to Requests for Additional Information 7-38, 7-40, and 7-48
ML22249A1252022-08-31031 August 2022
Shine Technologies, LLC Final Safety Analysis Report - Application for an Operating License Supplement No. 30, Cover Letter
ML22105A1102022-08-26026 August 2022
Shine Medical Technologies LLC - Request for Additional Information Related to the OGC Review of Phrase Approach
ML22061A2122022-08-24024 August 2022
Shine Medical Technologies LLC - Regulatory Audit Plan for Phased Approach - Session 1
ML22187A1342022-08-0101 August 2022
Shine Technologies, LLC - Update to Operating License Application Technical Review Schedule
ML22213A0492022-08-0101 August 2022
Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information
ML22206A2082022-07-27027 July 2022
Shine Medical Technologies, LLC - Request for Confirmatory Information Related to Radiation Protection Program and Waste Management
ML22207A0062022-07-26026 July 2022
Shine Technologies, LLC Application for an Operating License Supplement No. 29
ML22202A4492022-07-21021 July 2022
Shine Technologies, LLC Operating License Application Supplement No. 28 - Submittal of a Revision to the Shine Emergency Plan
ML22188A2412022-07-14014 July 2022
Meeting with Shine Medical Technologies, LLC (EPID No. L-2019-NEW-0004), to Discuss Development of Shine'S Cybersecurity Program for It'S Medical Isotope Production Facility
ML22175A0392022-07-11011 July 2022
Letter to Reid Nelson, Achp Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility
ML22175A0542022-07-0808 July 2022
Letter to Gregory Piefer - Notice of Availability of the Draft EIS Supplement Related to the Operating License for the Shine Medical Isotope Production Facility
ML22175A0912022-07-0808 July 2022
Notice of Availability and Request for Comments on the Draft Environmental Impact Statement Supplement Related to the Operating License for the Shine (Multiple Tribal Letters)
ML22175A0772022-07-0808 July 2022
Letter to Daina Penkiunas - Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility
ML22175A0632022-07-0808 July 2022
Letter to Ken Westlake, EPA Region 5 - Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility
ML22188A1942022-07-0707 July 2022
Shine Technologies, LLC, Application for an Operating License Supplement No. 27
ML22188A0562022-07-0707 July 2022
Shine Technologies, LLC Operating License Application Supplement No. 26 Submittal of a Revision to the Shine Material Control and Accounting Plan
2024-05-07
[Table view] |
Text
April 17, 2017 Gregory Piefer, Ph.D.
Chief Executive Officer SHINE Medical Technologies, Inc.
101 E. Milwaukee Street, Suite 600 Janesville, WI 53545
SUBJECT:
SHINE MEDICAL TECHNOLOGIES, INC. - ACKNOWLEDGMENT OF CHANGE OF MAILING ADDRESS
Dear Dr. Piefer:
By letter dated December 9, 2016 (Agencywide Documents Access and Management System
[ADAMS] Accession No. ML16344A021), SHINE Medical Technologies, Inc. (SHINE) informed the U.S. Nuclear Regulatory Commission (NRC) of a change in its mailing address.
The NRC has updated its records to reflect this change and will send all correspondence to the following mailing address:
SHINE Medical Technologies, Inc.
101 E. Milwaukee Street, Suite 600 Janesville, WI 53545 If you have any questions, please contact Steven Lynch at 301-415-1524, or by electronic mail at Steven.Lynch@nrc.gov.
Sincerely,
/RA/
Steven T. Lynch, Project Manager Research and Test Reactors Licensing Branch Division of Policy and Rulemaking Office of Nuclear Reactor Regulation Docket No. 50-608
ML17102B375; *concurred via email NRR-088 OFFICE NRR/DPR/PRLB/PM* NRR/DPR/PROB/LA* NRR/DPR/PRLB/BC NAME SLynch NParker AAdams DATE 4/13/17 4/13/17 4/17/17